InvestorsHub Logo
icon url

packerfanbud

06/25/13 8:47 AM

#60259 RE: BuddyGuise #60258

my thought is there is a large expense attached to the initial roll out of a drug. We should see cost decline and revenue rise for the current portfolio this next year.